ACT, an Indian venture philanthropy platform, has committed Rs. 8.33 crore in catalytic grants to Khushi Baby and Medoplus; social startups that are pioneering tech-first solutions to revolutionise ...

Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, announced several ...

Vistagen, a late clinical-stage company dedicated to pioneering neuroscience based on nose-to-brain neurocircuitry, announced positive results from an exploratory phase 2A study of PH284 in cancer ...

Signet Therapeutics (Signet), a clinical-stage biotech company leveraging organoids and AI to develop first-in-class cancer therapies, announced that the first patient has been dosed in the phase I ...

Acadia Pharmaceuticals Inc., a company is advancing breakthroughs in neuroscience to elevate life, announced that the company has submitted a Marketing Authorization Application (MAA) to the European ...

Olfactive Biosolutions, the leader in adapting food molecules to treat chronic diseases, was recently granted a third patent for inducing the secretion of GLP-1 and GIP, in US patent US 12,171,727 B1 ...

Pasithea Therapeutics Corp., a clinical-stage biotechnology company developing PAS-004, a next-generation macrocyclic MEK inhibitor, for the treatment of neurofibromatosis type 1 (NF1) and other ...

MedMira Inc. (MedMira) announced that it has received the approval from Health Canada for its Reveal Rapid G4 HIV-1/2 Test (Reveal HIV test) for Point-of-Care (POC) use. The Reveal HIV rapid test has ...

The Government of India has amended the rule to allocate the handling of matters related to Health Technology Assessment (HTA) to the Department of Health Research (DHR) under the ministry of health ...

Raising concerns over the content of a circular issued by the CDSCO on December 17 last year, the secretary of the Maharashtra State Chemists and Druggists Association (MSCDA), Anil Navandar, has ...

The Pharmacy Council of India (PCI) has revised the list of pharmacists blocked on its DIGI-PHARMed portal from 45,355 to 91,586 entries, and asked the listed pharmacists to create new registration on ...